Eu
Eupraxia Pharma
Victoria CAFounded 201130 employees
Private CapbiotechPrivateMusculoskeletal
Platform: Extended Rel Inject
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| EUP-1431 | EUP-1431 | Phase 2 | 2 | PRMT5 | DLBCLMCC | ||
| EUP-4341 | EUP-4341 | Preclinical | 1 | TIM-3 | Hemophilia A |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)